Clinical trials recruiting in Algeria

Phase breakdown

Cities in Algeria

Conditions recruiting in Algeria

Recruiting trials in Algeria

• ALG-LungCancerRegistry (SAFRO2202)
  NCT07161882 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast Cancer
  NCT07166185 · Phase: Not specified · Ages: 19 Years and older · Sex: Female
• OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme
  NCT07779343 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.
  NCT05190094 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female
• Pregnancies Before the Diagnosis of Systemic Lupus Erythematosus
  NCT07148115 · Phase: Not specified · Ages: 18 Years to 55 Years · Sex: Female
• Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease
  NCT07542496 · Phase: Not specified · Ages: 19 Years and older · Sex: Female
• Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
  NCT07484971 · Phase: Not specified · Ages: 19 Years and older · Sex: Male

Common questions

How many clinical trials are recruiting in Algeria?

7 recruiting trials have at least one study site in Algeria.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.